glp 1 drugs contraindications Table 5 from Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Drug Class Review Glucagon-like Receptor-1 agonists for obesity:

Effect of GLP1 receptor agonists on prostate cancer risk reduction: a systematic review and metaanalysis

Tirzepatide Tirzepatide, developed by Eli Lilly, is available on the market under two brand names: Mounjaro is FDA-approved for use in conjunction with diet and exercise to improve glycemic control in adults with T2D

Clinical data suggests the drug supports meaningful weight loss and can be taken without strict food or timing requirements, potentially improving ease of use and adherence

Pharmaceuticals 18 , 214 (2025)

Waiting less than 30 minutes or taking with food or beverages other than plain water will lessen the effect of the medication

Encouragingly liver injury was not seen in any of the patients who took the drug in the trial and the side effects they experienced were similar to those encountered using the drug in an injectable form